Amgen
AMGN
$271.31
Share price
0.73%
Change (1 day)
-5.06%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Earnings for Amgen (AMGN)
Earnings in 2023 (TTM): $8.75 B
According to Amgen's latest financial reports the company's current earnings (TTM) are $8.75 B. In 2022 the company made an earning of $7.34 B an increase over its 2021 earnings that were of $6.70 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Amgen from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $8.75 B | 19.13% |
| 2022 | $7.34 B | 9.63% |
| 2021 | $6.70 B | -17.61% |
| 2020 | $8.13 B | -11% |
| 2019 | $9.13 B | -4.26% |
| 2018 | $9.54 B | -0.54% |
| 2017 | $9.59 B | 4.74% |
| 2016 | $9.16 B | 14.85% |
| 2015 | $7.97 B | 42.85% |
| 2014 | $5.58 B | 6.08% |
| 2013 | $5.26 B | 5.11% |
| 2012 | $5.00 B | 20.7% |
| 2011 | $4.15 B | -21.95% |
| 2010 | $5.31 B | 2.17% |
| 2009 | $5.20 B | -0.88% |
| 2008 | $5.25 B | 32.54% |
| 2007 | $3.96 B | -1.47% |
| 2006 | $4.02 B | -17.42% |
| 2005 | $4.86 B | 43.39% |
| 2004 | $3.39 B | 6.99% |
| 2003 | $3.17 B | -550.4% |
| 2002 | -$0.71 B | -141.78% |
| 2001 | $1.68 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.43 B | 179.25% | 🇺🇸 USA |
 Pfizer PFE | $12.25 B | 40.01% | 🇺🇸 USA |
 AbbVie ABBV | $8.00 B | -8.55% | 🇺🇸 USA |
 Eli Lilly LLY | $6.14 B | -29.81% | 🇺🇸 USA |
 Biogen BIIB | $1.60 B | -81.61% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.23 B | -17.30% | 🇺🇸 USA |
 Illumina ILMN | -$0.18 B | -102.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.62 B | -1.44% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $9.02 B | 3.11% | 🇬🇧 UK |